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ABSTRACT
PRODUCTION AND CHARACTERIZATION OF COMPOSITE NANO/MICRO
SIZED PARTICLES BY RAPID EXPANSION OF SUPERCRITICAL
SOLUTIONS (RESS) CO-PRECIPITATION
by
Beidi He
Nanoscale composites of hexahydro-1, 3, 5-trinitro-1, 3, 5-triazine (RDX) and polymer
binders were produced by co-precipitation using rapid expansion of supercritical
solutions (RESS). The binders used in this study are poly (vinylidene fluoride-cohexafluoropropylene) (VDF-HFP22), polystyrene (PS) and 7-amino-4-methyl coumarin
(AMC). The RDX/VDF-HFP22 and RDX/PS co-precipitated nanoparticles were
characterized by Field Emission Scanning Electron Microscopy (FE-SEM) and
Transmission Electron Microscopy (TEM). The average size of produced nanoparticles is
ca. 100 nm. TEM analysis of RDX/PS nano-composite shows a core-shell structure with
RDX as the core material and the shell consisting of the polymeric binder. X-ray Powder
Diffraction (XRPD) analysis indicates polycristalline structure of RDX in the product
with a crystallite size of 42 nm. The content of RDX in the composite particles is in the
range 70-73% by mass as determined by Gas Chromatography-Mass Spectroscopy (GCMS) and by XRPD.
Micronized composites of ibuprofen and bio-compatible polymer binders were
produced by co-precipitation in rapid expansion of binary supercritical solutions (RESS).
The binders used in this study are poly-L-lactic acid (PLLA), poly (lactic-co-glycolic
acid) (PLGA), and polyethylene glycol (PEG). The recrystallized particles of pure

ibuprofen as well as produced by ibuprofen co-precipitation with a polymer binder were
characterized by optical microscopy. The average ibuprofen particle sizes are 1-3 microns
depending on the process conditions. The particle size increases proportionally to the
cubic root of the solute concentration in the supercritical solution in CO2. The coprecipitated ibuprofen/polymer particle size is in the range of 3-10 microns. In vitro
dissolution rates were measured at ambient temperature as well as at 37 °C. Polymer
coated ibuprofen particles produced by RESS co-precipitation dissolve in water at
ambient temperature from 10 to 20 times faster than the original ibuprofen powder. At
37 °C the dissolution is from 2 to 3 times faster compare to the original powder. The
acceleration of the dissolution rate is due to the much smaller particle size as well as the
presence of polymer layers which prevent particle agglomeration.
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CHAPTER 1
INTRODUCTION

1.1 Supercritical Fluid Technology for Particulate Matter Engineering
Supercritical fluids have been widely studied for the last three decades on their
applications in materials preparation and processing. One of the most distinguishable
properties of supercritical fluids is the tremendous change in the solvation power upon
variations of temperature and pressure. The solvation power is closely related to the
density of a supercritical solution which significantly varies with pressure at a given
temperature. By tuning the external temperature and pressure the solvation power
changes dramatically, which makes supercritical fluid an ideal solvent for materials
dissolution and precipitation.
Supercritical fluid (SCF) technology has been widely used in particle
engineering due to processing versatility unavailable with conventional solvent-based
techniques. A wide range of chemical compounds can be chosen as supercritical
solvents. Among them, carbon dioxide (CO2) has become the most widely used.
Carbon dioxide is inexpensive, nontoxic, and has relatively mild critical conditions,
making it especially suitable as a processing medium.
Numerous SCF-based approaches have emerged for the formation of ultrafine
particles. These technologies can be divided into two principal motifs. Some use SCFs
as a solvent while the others use SCFs as an anti-solvent. Rapid expansion of
supercritical solutions (RESS) technology is one of the most widely used processes
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utilizing SCFs as the solvent, which has been employed for the production of
ultra-fine nano-sized and micron-sized powders (1-7). The approach utilizes strong
dependence of the solvent strength of the SCFs on both temperature and pressure. As
a result, by variation the process parameters the size and the morphology of the
precipitated material produced by RESS could be modified. The pre-expansion
pressure and temperature control the solubility of the solute in the supercritical carbon
dioxide, which control the particle size. The expansion nozzle geometry as well as
temperature and pressure in the expansion vessel control the size as well as the
morphology of the produced particles. Expansion of supercritical solutions leads to
drastic pressure and temperature drops, resulting in the supersaturation levels above
107 (8). At such high supersaturations, formation of small particles is favored, as the
critical nucleus size can be as small as a single molecule (9). In addition, since the
pressure change travels at the speed of sound (10) right after the nozzle where most
particles are formed, the uniform conditions might result in a relatively narrow
particle size distribution.
The RESS method in producing small particles is limited by the material’s
solubility in supercritical fluid. For processing materials that are poorly soluble in
SCFs, a commonly used alternative is to use a SCF as an anti-solvent. Their
effectiveness as an anti-solvent stems from their high diffusivity in liquids, whereby
precipitation can be rapidly achieved by the expansion of the liquid solution with an
SCF (11). Supercritical anti-solvent precipitation (SAS) technology is a common form
of processing utilizing this phenomenon (12).

2

1.2 Supercritical Fluid Technique for Particle Coating
Particle coating has attracted significant interest because by combining different
materials having different physical and chemical properties to form composites, new
functionality or improved properties of the known materials could be achieved.
However, conventional wet coating method introduces organic solvents which are
toxic and difficult to remove. In the case of dry coating (13), one requirement is that
the core material and the coating material need to be pre-manufactured to form small
particles. This imposes a strict limit on the particle size. Also, it stems from the
application of dry coating process to form thin layer of coating film, and the process is
complicated.
Coatings of nano-sized powders encounters several complications. Traditional
methods such as water-based slurry coating become much less effective with very
small particles. One issue is the difficulty in the dispersion of nanoparticles as they
commonly exhibit a strong tendency to form agglomerates. This can result in a very
non-uniform distribution of binder in the coated material. Another complication stems
from the poor stability of nanoparticles in liquid suspensions. Ostwald ripening,
which becomes significant at such small particle sizes, can detrimentally alter the
particle size distribution. In a study aimed at characterizing the microstructure of
slurry coated nanocrystalline RDX, it was shown that during coating of this material
with a wax binder, which was achieved by a traditional slurry coating process, the
RDX underwent extensive ripening (14).
Therefore, supercritical fluid technology is also applied in the field of small

3

particles coating. There are several types of techniques for particle coating using the
supercritical fluid processing: Supercritical anti-solvent (SAS), Particles from gas
saturated solutions (PGSS), and Rapid expansion of supercritical fluid (RESS).
In SAS (15), the coating material is dissolved in a conventional organic
solvent, in which the core particles are suspended. Then a high-pressure supercritical
fluid is injected into the solution, which causes the solution to expand. In this process,
the core material needs to be pre-manufactured and an organic solvent is involved. In
PGSS (16), a supercritical fluid is saturated with a liquid coating material. The core
particles are also suspended in the liquid coating material. Particles are formed by
rapid expansion of the saturated solution through a nozzle. This process is operated at
moderate pressures as compared to RESS. It needs the supercritical fluid to be highly
soluble in the liquid phase, which makes amorphous polymers suitable to be the
coating material. Again, the core material is also pre-manufactured.
In RESS, the coating material would be extracted by a supercritical fluid to
form a supercritical solution. Then the solution rapid expands through a nozzle.
Deposition of thin, uniform coatings by expansion of supercritical solutions has been
previously reported. Tsutsumi et al. (17) successfully used the RESS technology to
coat paraffin wax onto submicron catalyst particles with a thickness of the paraffin
layer of ca. 40 nm. Mishima et al. (18) employed the RESS process to effectively
encapsulate ca. 15 μm protein particles in

polymers. Glebov et al. (19) used RESS

to produce polymeric films on fused silica plates and metal (Al, Mg) powders. A key
distinction of the approach investigated in this work is that the core material is formed
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during the same processing step as the coating, while in the reported studies the core
materials was pre-manufactured.
Manufacturing of a composite material by dissolution of both components in
supercritical fluid to make a binary solution had also been reported. In several studies
(18, 20), a semi-batch process was used, where CO2 first was saturated with the
ingredients (the drug and the coating material) in confined vessels. After that, the
mixture of the solution was expanded through a nozzle. In this approach, the amount
of the material produced in one cycle is limited by the saturators’ volumes as well as
the solutes solubility in supercritical carbon dioxide. Moreover, in this approach, the
conditions are changing during the expansion process which complicates the
assessment of the impact of the process conditions on the product properties.
In the approach used in this study, we developed a continuous extraction and
expansion system which overcomes the restrictions associated with the limited
volume as well as the limited solubility of the solutes in supercritical carbon dioxide.

1.3 Particles Coating in Pharmaceutical Applications
Bioavailability is an important factor in drug design and medical applications of a
drug (21). Many successfully designed and synthesized prospective chemical
substances either have limited functionality as drugs or are even completely useless
because of their low bioavailability (22-24). One of the factors that limit
bioavailability of some drugs is low solubility in water (25-27). For poorly
water-soluble drugs, their rate of absorption in the gastrointestinal tract depends on
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the dissolution rate. Therefore, enhancement of the dissolution rate might improve the
efficiency of certain drugs in the biological environment. One of the ways to increase
the dissolution rate is the reduction of the particle size. Micronization is one of the
commonly used methods to improve the drug dissolution rate. Traditional methods for
micronization include grinding, milling, and spray-drying. However, these approaches
result in wide particle size distribution and often introduce undesirable organic
solvent residue (28). Even much smaller particles, if manufactured, are to be protected
from agglomeration. This involves usage of a bio-compatible excipient with good
solubility in water. Such a formulation, consisting of a very small drug particles
(micron and submicron range) mixed with a bio-compatible polymer matrix is
expected to dissolve much faster than larger (10–100 μm) particles of a low solubility
substance.
However, production of such compositions using standard techniques
encounter difficulties associated with the problems of homogeneous mixing of
micronized powders (29-31). In this work we suggest a technology which allows
preparation of homogeneously micronized mixtures in a single technological step. In
addition, the proposed technology is free from organic solvents, which is beneficial
both from the point of view of strict regulations on the residual organic solvents (32)
as well as environmental contamination issues.
Ibuprofen is a widely used pain relieving drug. However, this substance has
poor solubility in water which has a negative impact on the drug performance. Low
solubility delays the pharmaceutical action. To achieve faster response, the
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formulations use larger amounts of the active pharmaceutical ingredients (5). The
increase of the dissolution rate might mitigate the problem. Ibuprofen has a relatively
high solubility in supercritical carbon dioxide (33). In this study we applied the
technique to the production of micronized ibuprofen/biocompatible polymer
composites.
Among prospective substances to be used as supercritical fluid solvent, carbon
dioxide has several advantages. Carbon dioxide is non-toxic, economic; the
production can be arranged in an environmentally friendly closed loop process.
Previous studies on exploration of RESS technology for drug micronization (34-37)
had been reported. One of the major problem encountered is agglomeration of the
produced particles (5). Attempts to sieve micronized ibuprofen produced by RESS
through a 250 μm mesh or physically mixing it with lactose did not improve the rate
of dissolution. A thin polymer coating of the micron-sized particles could protect the
drug particles from agglomeration in the composition. In addition, utilization of a
highly soluble polymer might facilitate separation of the particles in the process of
dissolution. Such polymer coated micron and submicron particles could be produced
by a modification of the RESS technology. Rapid expansion of binary supercritical
solutions of a drug with a highly soluble biocompatible polymer could be a solution of
the agglomeration problem.

1.4 Objectives of Research
In a preceding study, the RESS technology was employed to produce high quality and
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purity nanocrystals of hexahydro-1, 3, 5-trinitro-1, 3, 5-triazine (RDX), a common
military high explosive used in numerous munitions. The nanocrystalline form of
RDX showed a dramatic decrease in the initiation sensitivity to mechanical stimuli
including shock and impact, which are key sources of accidental initiation (38). High
explosives are rarely used in their pure form, rather, coating with a polymeric or wax
binder is typically required. In this work, an alternative method for encapsulating
RDX nanocrystals with a binder was investigated. The aim was to augment the
existing RESS process with in-situ coating of the newly formed RDX nanocrystals
with a polymeric binder. To accomplish this, the earlier RESS method (1) was
modified by dissolving a polymeric binder together with RDX in supercritical CO2.
This would necessarily cause both solutes to co-precipitate during RESS. In order to
verify whether the desired structure was obtained with core RDX nanocrystals coated
with a thin polymeric layer, transmission electron microscopy was employed.
In this work, the RESS technology was also employed to produce high quality
and purity microcrystals of ibuprofen as well as ibuprofen and biopolymer composites
using continuous rapid expansion of binary supercritical solutions. With the
fundamental understanding of the structures and morphology obtained by the
co-precipitation of RDX and polymer binders. The continuous RESS technique to the
pharmaceutical application is scaled-up. Ibuprofen was known to have 1000 times
higher solubility as compared to RDX in supercritical carbon dioxide. The
experiments are designed to apply the continuous RESS method for ibuprofen and
some bioavailable polymers co-precipitation. The dissolution kinetics of the produced
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materials was studied to evaluate the pharmaceutical benefits. Comparison of the
dissolution behavior of the co-precipitated material with the unprocessed ibuprofen
provided additional information on the morphology of the materials produced by the
co-precipitation process.
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CHAPTER 2
CO-PRECIPITATION OF RDX AND POLYMERS COMPOSITE BY RESS

2.1 Materials
Pure RDX was obtained by recrystallization of commercial RDX from acetone to
eliminate impurities (mainly 12% of HMX in the initial material). VDF-HFP22, a
poly(vinylidene fluoride-co-hexafluoropropylene) copolymer with 22 mol %
hexafluoropropylene, was purchased from 3M, with a purity of 99+%, and a MW of
85,000 g/mol. Polystyrene was obtained by dissolution of Styrofoam #6 in toluene
with subsequent precipitation (MW of ca. 250,000 g/mol, purity 99%). AMC
(7-amino-4-methyl-coumarin) (99.9%) was purchased from AnaSpec Inc., with a
purity of 99.9%. Common organic solvents were used as purchased. Acetone (99.5+%,
ASC grade) was purchased from Sigma Aldrich. Toluene (99.9%, HPLC grade) was
purchased from Fisher Scientific. Carbon dioxide (99.8+%, bone dry grade) was
purchased from Scott Specialty Gases. Liquid CO2 was supplied in cylinders with a
siphon tube and pressurized with helium to 103 bar.

2.2 Experimental Set-up
The experimental setup is schematically shown in Figure 2.1. It consists of a carbon
dioxide supply system, a Thar P-50 dual piston pump (Thar Designs Inc.) with a
maximum discharge pressure of 350 bar and a maximum flow rate of 50 g/min, an
RDX extraction vessel (1.27 cm ID, 35 cm long), a binder extraction vessel (1.27 cm
ID, 35 cm long), and an expansion system.
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Figure 2.1 The experimental set-up. 1: CO2 cylinder (liquid CO2, pressurized with
helium, equipped with educator tube); 2: Dual piston pump; 3,4,6: Ovens; 5: RDX
extraction vessel; 7: Binder extraction vessel; 8: Nozzle; 9: Temperature monitor; 10:
Expansion chamber.

All connections are made of 3.175 mm OD stainless steel tubing and SS
Swagelok unions. The two extraction vessels are heated by two temperature
controlled ovens. The connecting tubings are heated by variac powered heating
elements. Four K-type 3.175 mm thermocouples are used to measure temperatures of
the system elements. The thermocouples were placed in the RDX extraction vessel,
inside the connecting tubing between the two extraction vessels using a union tee
fitting (Swagelok), inside the tubing after the second extraction vessel again using a
union tee fitting, and inside the supply tubing 50 mm before the stainless steel
expansion nozzle. The cylindrical expansion/collection vessel prevented the
co-precipitated RDX/binder powders from being influenced by moisture from
entrainment of ambient air. The expansion vessel is made of transparent acrylic resin

11

with a 40 mm ID and is 36 cm long. The nozzle has an orifice with the inner diameter
of 100 μm and a length of 3 mm.
Liquid carbon dioxide withdrawn through the dip tube on the supply cylinder
was fed to the pump. The pump output pressure was chosen by adjusting the mass
flow rate using the pump controller. The pump piston heads and the incoming carbon
dioxide were chilled to -5 °C for maximum pumping efficiency. Downstream from
the pump the liquid carbon dioxide was preheated to the desired temperature in an
oven prior to being fed to the extraction vessels. The RDX and polymer extraction
vessels were packed with 3 mm diameter glass beads on which the respective solutes
were deposited. The beads were used to significantly increase the surface area to
accelerate dissolution of polymers in supercritical CO2. In the first vessel, the glass
beads were coated with solid RDX (by wetting with a solution of RDX in acetone
with subsequent drying). In the second vessel, the beads were coated with a polymer
binder (either VDF-HFP22 deposited from a solution in acetone or polystyrene
deposited from a solution in toluene). Supercritical solution of RDX and the binder is
transferred through a heated, 3.17 mm stainless steel tube to the nozzle assembly
where it is expanded to ambient pressure. The nozzle was uniformly heated with
embedded heating elements to prevent blockage due to accumulation of dry ice as a
result of drastic cooling of the feed solution during expansion. The product is
collected on wax paper or glass substrates placed at the bottom of the expansion
vessel.
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2.3

Procedure

To preload the binder onto the glass beads in the vessel, 1 ml of binder solution (0.2 g
VDF-HFP22 dissolved in 10 ml of acetone or 0.2 g polystyrene dissolved in 10 ml of
toluene) was added drop-wise to the binder extraction vessel and dried in ambient air
flow (vacuum pumped). RDX solutions were prepared by dissolving 0.4 g RDX in 10
ml of acetone. The coating of the beads was performed in a similar manner, 2 ml of
the RDX solution was added drop-wise to the RDX extraction vessel also filled with
glass beads, followed by drying with ambient air flow for 2 min. After drying, the
heaters were turned on to reach the desired temperatures. The RDX vessel
temperature was varied in the range 70-80 °C. The binder vessel temperature was
varied in the range 100-110 °C. The expansion nozzle was maintained at 50 °C. After
temperature stabilization for ca. 10 min, the high-pressure dual piston pump was
turned on and liquid CO2 was pumped at a constant flow rate. To collect adequate
quantities of the products, typical runs lasted 15 min.
The initial material collected on the bottom of the expansion vessel was solid
carbon dioxide (powdered dry ice) with entrained nanoparticles of RDX/binder. The
product was left for ca. 1 h for carbon dioxide to sublime. The residual powder on
wax paper or glass substrates was weighed and stored for further characterization. The
RDX and binder vessels were disconnected from the system and weighed before and
after each run to monitor the rate of consumption of RDX and the binder. The
experimental conditions used in the preparations of the samples are summarized in
Table 2.1.
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Table 2.1 Summary of Co-precipitated Nano-particles Produced by RESS
No.

Component

Temperature

Pressure

/°C (mean)

/bar (mean)

wt. % RDX

I

RDX

52

200

100

II

RDX/VDF-HFP22

48

200

70

III

RDX/PS

53

205

72

IV

RDX/PS

50

150

72

V

RDX/PS

51

130

72

2.4 Physical Properties of Co-precipitated RDX/polymer Composite

2.4.1

X-ray Powder Diffraction Analysis

X-ray Powder Diffraction (XRPD) analysis of prepared materials was performed
using a Philips PW3040 X-Ray Diffractometer. Cu Kα radiation was employed for
crystal structure analysis as well as crystallite size analysis in the RDX/VDF-HFP22
nano-composites. Furthermore, quantitative analysis of constituents in the product
materials was performed with XRPD.
For quantitative determination, samples of the precursor RDX from 1.2 to 90
mg were scanned for calibration. The scattered intensity was recorded in the range
26°≤ 2 𝜃 ≤ 30° in steps of 0.008°with a counting time of 0.96 s per step. The RDX
powder was dissolved in acetone (1.5 g RDX/20 g acetone). For calibration, one to
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thirty drops of the RDX solution were placed on quartz plates; the weights of the
produced polycrystalline RDX were measured after acetone evaporation. A 15 mm
beam width, a 1/2° incident beam divergence slit, and a 1/2° diffracted beam
antiscatter slit were used. The X-ray diffractograms of different mass of the RDX
(Figure 2.2) precursor showed orthorhombic structure.

2θ
Figure 2.2

/

degrees

XRPD pattern of precursor RDX.

The major characteristic diffraction peaks of RDX are at 2 θ = 12.95, 25.21,
26.77 and 32.17°, which are in conformity with the crystal faces of (111), (131), (113)
and (223) of RDX (39). After Fourier transform smoothing and the background
subtraction, the diffraction peaks were integrated. The peak area is increasing linearly
with the mass of RDX (Figure 2.3).
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Mass of RDX / g

Figure 2.3 Calibration curve of the integrated RDX peak areas from XRPD
measurements. RDX mass is in the range of 1.2-90 mg.

The precursor RDX, the RESS recrystallized RDX (sample I), VDF-HFP22
polymer, and the RESS co-precipitated RDX/VDF-HFP22 composite (sample II) were
scanned by XRPD in series for crystal structure study. Specimens of each material
(0.15 g) were scanned separately in a 4 cm long × 2 cm wide × 0.5 cm deep stainless
steel sample holder. Data was recorded in the range 10°≤ 2 𝜃 ≤ 45°, which is the
full pattern range for standard RDX in the database (39) as shown in figure 2.4. The
samples were scanned in steps of 0.019°with a counting time of 1s per step. A 15 mm
beam width, a 1°incident beam divergence slit, and a 1°diffracted beam antiscatter
slit were used. Figure 2.5 shows an expansion in the diffraction angle range of 26-30°.
The XRD diffractogram of the VDF-HFP22 film shows amorphous broad halo which
represented its average polymer chain separation at 2 θ = 12-22°. In Figure 2.4d,
every single peak was broadened due to the small RDX crystallite size in the
composite.
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counts
/
Intersity
Figure 2.4 XRPD patterns of 0.15 g RDX precursor, RESS recrystallized RDX
(sample I), VDF-HFP22 and RESS co-precipitated RDX/VDF-HFP22 (sample II).
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counts
/
Intersity

2θ

/

degree

Figure 2.5 XRPD patterns in smaller angle range of 0.15 g RDX precursor, RESS
recrystallized RDX (sample I), VDF-HFP22 and RESS co-precipitated
RDX/VDF-HFP22 (sample II).
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Figure 2.5 also showed amorphous broad halo as a background which
represented the average chain separation of coated VDF-HFP22. Compared to the
precursor (large) RDX crystals, the diffraction line in the nano-RDX is broadened and
has lower peak intensity. By integrating the peak area of RDX/VDF-HFP22 in the
diffraction angle range of 26-30°, the RDX mass content in the nano-composite was
determined as about 73 wt.%.
According to the Scherrer equation (40), the diffraction lines are broadened
due to the small size of the crystallites. The crystallite dimensions can be calculated
using equation 2.1:

𝐷𝑣 =

𝐾𝜆
𝛽𝑠 𝑐𝑜𝑠𝜃

(2.1)

where Dv is the volume weighted crystallite size. The parameter K is the Scherrer
constant, which is usually considered to be equal to 1; λ is the wavelength of the
X-rays used; βs is the broadening due to the small crystallite size; θ is the X-ray
diffraction angle. The broadening due to the microstrain in the crystals, βstr, as well as
the broadening due to the instrument, βinst, (which is usually set to 0.07) should also
be considered (41). Assuming that the shapes of the broadened diffraction peaks for
both the size and the strain components are Lorentzian, the total integral breadth
(defined as the ratio of the peak area to the peak height) is obtained by adding the
three contributions together:
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𝛽𝑡 = 𝛽𝑠 + 𝛽𝑠𝑡𝑟 + 𝛽𝑖𝑛𝑠𝑡

(2.2)

According to Stokes and Wilson (42), the broadening due to the microstrain can be
estimated using equation 2.3:

𝛽𝑠𝑡𝑟 = 4 𝜀 𝑡an(𝜃)

(2.3)

Here ε is a measure of the microstrain which usually originates from the crystal
defects.
Combining equations (2.1), (2.2), and (2.3), the Williamson-Hall plot (43) can be
drawn:

(βt – 0.07) cos(θ)
λ

=

1
Dv

+

4 ε sin(θ)

(2.4)

λ

Therefore, by plotting (βt - 0.07) cos(θ) / λ vs. 4 sin(θ) / λ, dv and ε can be
determined.

Table 2.2 Scherrer Peak Broading Analysis Parameters (Sample II in Table 2.1,
Composite RDX/VDF-HFP22)

2θ
/degree

2 sin(θ)/λ
/nm

-1

FWHM

(β=βstr+βs)

β cos(θ)/λ

/degree

/radians

/nm-1

12.9

2.27

0.660

5.15×10-3

3.29×10-2

25.2

2.83

0.682

5.34×10-3

3.38×10-2

26.7

3.00

0.705

5.54×10-3

3.50×10-2

32.1

3.59

0.756

5.99×10-3

3.74×10-2
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The full width at half maxima of the peaks (FWHM) for the four main peaks
of the RDX scattering pattern at 12.95, 25.21, 26.77 and 32.17° (2θ) are listed in
Table 2.2.
The peaks were integrated and their areas were divided by the peak heights.
After that, the instrument broadening factor was subtracted. Figure 2.6 shows the
Williamson-Hall plots for RDX precursor (44), RESS produced nano-RDX (44), and
co-precipitated composite RDX/VDF-HFP22. The volume-weighted RDX crystallite

-1

(nm )

size in the composite determined from the Williamson-Hall plot is ca. 42 nm.

-1

(nm )
Figure 2.6 Williamson-Hall plot for (a) RESS co-precipitated RDX/VDF-HFP22
(material II), (b) RESS recrystallized RDX (44), and (c) unprocessed RDX (44).

This is similar to the crystallite size of pure nano-RDX (44 nm (44)), but
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smaller than the particle size observed by SEM. This indicates that there are multiple
RDX crystallites inside the composite particles. This observation is in accord with the
previous study (at somewhat different conditions, 80 °C and 280 bar), where the
crystallite size of the RESS recrystallized RDX was 44 nm (Figure 2.3b (44)). Both
the nano-composite and nano-RDX crystallite size are much smaller than the
crystallite site of unprocessed RDX (44).
The Williamson-Hall plot for the composite nano-particles also indicate larger
internal strain in the crystallites compared to the nano-RDX but smaller than in the
precursor (as determined from the slopes) of the Williamson-Hall plot Figure 2.6.

2.4.2

Gas Chromatography - Mass Spectroscopy Analysis

Gas Chromatography (GC) with Mass Spectroscopy (MS) analysis of prepared
materials was performed using an HP 6890 series GC and an HP 5973 MS using
electron impact ionization. Ultra-high grade purity Helium (99.999%, Airgas) was
used as the carrier gas. A 30 m × 0.25 mm ID × 0.25 μm film thickness HP-5MS
capillary column was used. The column flow was 1.0 ml/min. The column
temperature was held at 150 °C for 30 min. The injector temperature was 150 °C and
the detector temperature was 250 °C. The inlet was fitted with a double tapered liner
and set in splitless mode. The purge valve opened and split vent flow increased to 100
ml/min at 1.5 min after the injection to sweep any vapors remaining in the liner out to
the split vent. The mass spectra were acquired over the 12-550 m/z mass range.
Standard solutions of RDX were prepared and analyzed to determine the
retention time and the RDX mass-spectrum.
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Figure 2.7
signals.

RDX five point calibration plot of m/z = 46, 75, 120, and 128 MS

RDX was identified correctly using the NIST mass-spectra database search.
The retention time and the quantification ions which were used subsequently for RDX
determinations are 15.4 min; and m/z = 128, 120, 75, and 46. All quantifications were
based on the peak area of the MS signal. The stock solutions of RDX were made by
weighing 0.1 g (± 0.0001 g) of RDX and dissolving it in 5 ml of acetone in a
volumetric flask. The mass spectrums were taken and the retention times were
determined at different concentrations of RDX in the solutions. The calibration
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standards were prepared by diluting the stock solution with acetone in 1 ml
volumetric flasks. Five calibration standards were made containing RDX at
concentrations between 800 and 8000 μg/ml.
Peak areas of the analytes were then used to construct the calibration curves as
shown in Figure 2.7. Regression analysis was used to assess the linearity of the
analytical method. Five point calibration curves were constructed which produced
correlation coefficients (R2) greater than 0.994. The RESS co-precipitated
RDX/VDF-HFP22 and RDX/PS composites were analyzed to determine the mass
content of the two components. The RDX concentrations were determined using the
calibration plots. Figure 2.8 shows total ion chromatograms (TIC) in the calibration
measurements.

Figure 2.8 GC-MS total ion chromatograms for RDX standard solutions in the
range of 0.8-8.0 mg/ml.

The RDX peak has a retention time of 15.4 min. The same method was used to
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analyze sample II RDX/VDF-HFP22 nano-composite (Figure 2.9), which was
dissolved in acetone with concentration of 80 μg/ml, 100 μg/ml, and 2000 μg/ml,
respectively. GC-MS analysis requires much smaller amounts of the powders (ca. 2
mg vs. ca. 150 mg). By this analysis (based on the integration of the peak areas of
ions with m/z values of 46, 75, 120, and 128), the RDX mass content in the
RDX/VDF-HFP22 composite was determined as 70%, in good agreement with the
XRD quantitative analysis, which yielded 73% RDX mass content. The RDX/PS
nano-composite (sample III) and RDX/AMC nano-composite were evaluated using
the same method (Figure 2.10, Figure 2.11).

Figure 2.9
GC-MS total ion chromatograms for RESS co-precipitated
RDX/VDF-HFP22 nano-composite sample II (200 bar, 48 °C) dissolved in acetone
with concentrations 0.8, 1.0, and 2.0 mg/ml.
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Time / min
Figure 2.10 GC-MS total ion chromatograms for RESS co-precipitated RDX/PS
nano-composite dissolved in acetone with concentration of 900 μg/ml.

Time / min
Figure 2.11 GC-MS total ion chromatograms for RESS co-precipitated RDX/AMC
nano-composite dissolved in acetone with concentration of 1100 μg/ml.
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By subtracting the background and integrating the peak area, the measured RDX mass
content in RDX/PS and RDX/AMC nano-composite are ca. 72% and 80%,
respectively.

2.4.3

GC-MS Analysis on RDX/AMC Nanocomposite

2.4.3.1 Preparation and Storage of Standards. Stock standard solutions of RDX
(3000 µg ml-1) and AMC (1000 µg ml-1) were prepared in acetone. The solution was
sonicated in an ultrasonic bath (20 min) until a homogeneous and clear solution was
formed. The stock solution was stored at room temperature for a maximum of 1
month. Before use, standard working solutions were prepared by diluting appropriate

Abundance

amounts of the stock solution.

Figure 2.12 Total ion chromatogram of the RDX and AMC standards.
Concentration of analytes injected: RDX 500 µg ml-1; AMC 166 µg ml-1.
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The temperature of the GC injector was held at 150 ºC. Temperature of the
MS detector was at 230 ºC. The oven temperature was set at 150 ºC, held for 5 min,
increased to 170 ºC at 5 ºC min-1, held for 2 min, then to 230 ºC at 8 ºC min-1 and held
for 5 min. The peak areas were used to quantify the analytes.
The chromatogram of the standard mixtures of RDX and AMC under the
adopted GC conditions using the HP-5MS is shown in Figure 2.12. Good separation
of RDX and AMC was achieved. No column degradation was observed.
2.4.3.2 Linearity. The sensitivity of the GC method was tested by injecting standard
mixtures of the analyte (25-3000 µg ml-1). The calibration curves obtained by plotting
the integrated peak area against the concentration of the respective standards were
found to be linear over the range 25-3000 µg ml-1. The correlations coefficients are
0.9994 for RDX and 0.9972 for AMC (Table 2.3). Good linearity was obtained for the
same analytes when assessed over 6 days. The calibration plot is shown in Figure
2.13.

Figure 2.13

Calibration plots of the GC method used in the measurements.
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2.4.3.3 Reproducibility Study. The reproducibility of the retention time was assessed
by injecting the same standard solution (25, 50, 100, 200, 300, 400, 600, 800, 1000 µg
ml-1) over the period of 8 days. Each standard was injected 5 times, which resulted in
total 45 data points. The relative standard deviation (RSD) for the retention time
obtained for RDX is 0.37%, and for AMC is 0.97%. The low RSD values indicate that
the retention times were highly reproducible.

Table 2.3 Calibration Data of the GC Method Used
Analyte

Regression

Linearity

Correlation coefficient

µg ml-1

r2

equation
µg ml-1
RDX

y = 6.8×104 x

25-3000

0.9994

AMC

y = 3.3×104 x

25-1000

0.9972

2.4.4
Evanescent Excitation Microscopy of RESS Co-precipitated RDX/AMC
Powder
The experimental set-up is shown in Figure 2.14. An attempt to gain information on
the morphology of the particles produced by the method using optical microscopy was
made. The idea of the experiment was as follows. By precipitation of a binary solution
of RDX with a fluorescent dye and by comparing usual microscopic images with the
images taken in the fluorescence one might derive some conclusions on whether there
are particles made of different component or not.
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Figure 2.14

Evanescent excitation microscopy experiment set-up.

To this end, the total internal reflection fluorescence microscopy was
performed

for

RESS

co-precipitated

RDX/AMC

nanoparticles.

AMC

(7-amino-4-methyl coumarin) is a highly fluorescent material which could be excited
with a 351 nm laser light. Thin layers of the sample powders were placed on the
diagonal face of a right angle fused silica prism.

The laser beam is entering the

prism through a smaller face, is being refracted, completely internally reflected from
the diagonal face, and lives though the second smaller face, as shown in Figure 2.14.
Outside the diagonal face of the prism exponentially decaying electromagnetic wave
is formed (evanescent wave). The effective thickness of the evanescent field is about
the wavelength. This approach allows avoiding the illumination of the objective lens
with the laser pulse, and provides sensitive detection of the fluorescence of the AMC
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dye molecules. The fluorescence occurs at 422 nm (blue light). The image is recorded
using the gated ICCD camera.
Amino methyl coumarine (AMC) has short fluorescence lifetime of 1.9 ns (45).
The gate width of the ICCD camera was 2 μs, the laser pulse was triggered within the
gate.

The images were taken in fluorescence using laser excitation as well as

common images in light scattering using traditional light sources.
2.4.4.1 Sample Preparation. Nano-RDX/AMC samples made at 214 bar, 51.5 °C
and 198 bar, 37.3 °C were examined. 0.1 mg of either powder was placed on the
prism, 5 µl of acetone was used to spread the powder to make a flat surface to make a
sample.
Images of blank prism were acquired on daily bases

to make a blank

comparison. All of the blank images had “zero” (less than 5 counts/pixel after 1000
laser pulses) intensity in the photon counting mode.

3 μm

3___
μm

___

Figure 2.15 RESS co-precipitated nano RDX/AMC. Left – traditional microscopy;
right – evanescent excitation, the images are taken in fluorescence. Photon counting
maximum intensity: 205 counts/binned pixel. Gate width 2 µsec. gain 255,
discrimination thresholds 175-700, 8×8 binning pixel, microscope magnification
56×10 = 560.

31

Bulk RDX was also evaluated. It did not show any detectable fluorescence. In
the photon counting mode, the maximum intensity of fluorescence was ca. 500
counts/pixel. It should be noted, that the size of the particles shown in in Figure 2.15
is not resolved, the particles are broadened by diffreaction and not perfect focussing.
Therefore, the amount of matter could not be evaluated from these images.
Three locations of each sample were examined. Comparing the optical
microscopy images and the fluorescent microscopy images, all particles in the field of
view are fluorescent as shown in Figure 3.0, which means all the particles contain
AMC, no pure RDX was found. Although a number of images have been acquired, no
more definitive conclusions about the particle morphology (such as the component
partitioning and spatial distribution) have been derived.

2.4.5

Scanning Electron Microscopy Analysis

Microscopy of produced materials was performed using a LEO 1530VP Field
Emission Scanning Electron Microscope (FE-SEM). Nanoparticles were deposited on
a 1 cm × 1 cm glass slide, which was mounted on a 1.3 cm diameter aluminum stub
using an adhesive carbon tape and were sputter coated with carbon to a thickness of
ca. 200 Å using a Bal-Tec MED 020 HR Sputter Coater. The generated images are
shown in Figure 2.16. Figure 2.16a shows the morphology and the size of the RESS
recrystallized RDX nanoparticles. Figure 2.16b is the SEM micrograph of the sample
II, produced with both RDX and VDF-HFP22 loaded in the vessels. As it can be seen,
the RDX nanoparticles have a relatively narrow size distribution. The distribution
functions were obtained by manually measuring each particle area using Image-Pro
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Plus 6.0 software and calculating their equivalent diameter. For nano-RDX, the
frequency was plotted vs. the particle diameter from 0 to 400 nm and the increment of
50 nm. Total of 291 particles from three SEM images of the same sample were
analyzed. The average particle size is 160 ± 25 nm. Figure 2.16b shows the SEM
micrograph of the RESS co-precipitated RDX/VDF-HFP22 nanoparticles. The average
particle size of the co-precipitated RDX/VDF-HFP22 nanoparticles is 101 ±25 nm.

a

900 nm

b

900 nm

Figure 2.16 SEM micrographs of sample I, RESS recrystallized nano RDX made of
0.16 g RDX at temperature 52 °C and pressure 200 bar (a) and sample II, RESS
co-precipitated RDX/VDF-HFP22 nanoparticles made of 0.16 g RDX and 0.04 g
VDF-HFP22 polymer at temperature 48 °C and pressure 200 bar (b). On the right hand
side – the size distribution functions.
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Total of 447 particles from three SEM images of the same sample were
analyzed. The particles produced by co-precipitation appear to agglomerate more
readily, likely due to the presence of VDF-HFP22 polymer which has a relatively low
glass transition temperature (Tg = -20 °C). At low glass transition temperatures,
nanoparticles tend to agglomerate (46). The absence of individual particles in the
images is a result of plasticization of the polymer by CO2 (46). By comparing the
micrographs, it is apparent that the average particle size of RDX/VDF-HFP22 is ca.
25-50 nm smaller than that of pure RDX. This could be due to the impeding of the
RDX particle growth by the polymer layer.

2.4.6

Transmission Electron Microscopy Analysis

Figure 2.17 TEM micrograph of sample II, RESS co-precipitated RDX/VDF-HFP22
nano-composite.
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Transmission Electron Microscopy of fabricated specimens was performed
with a Philips CM20 cryo-TEM/STEM. Nano-RDX/VDF-HFP22 composite (sample
II) powder was loaded onto a TEM grid and imaged using TEM under cryogenic
conditions. A representative TEM micrograph of sample II RDX/VDF-HFP22
nanoparticles (Figure 2.17) demonstrates the particles have near-spherical shape.
The particle size is ca. 100 nm. Here, the distribution of the polymeric binder
was not revealed due to the lack of contrast between the polymer and RDX. To
circumvent the problem, heavy element staining is commonly employed, typically
with RuO4. Ruthenium tetroxide was introduced as a differential stain. It is used to
label aromatic moieties from aliphatic ones. It can react with certain polymers to
enhance contrast during TEM imaging. It is a strong oxidizer and has shown
penetration depth of 100 nm within 15 min of reaction time (47). However,
VDF-HFP22 does not react with RuO4 and, therefore, another polymer must be used
for enhanced structural determination of the RESS co-precipitated RDX composites.
Polystyrene has been shown to be effectively stained by RuO4 (48). RuO4 vapor
covalently opens aromatic rings in polystyrene, RuO2 nanocrystal deposit on
polystyrene free surface. As polystyrene continuously exposed to RuO4 vapor, a
continuous film of electrically conductive RuO2 forms, which reduce the overall
contrast that obtained in transmission electron imaging. Therefore, polystyrene was
chosen as an alternative to VDF-HFP22 in preparation of RDX/binder nanocomposites.
The RDX/PS nanocomposite (sample III) prepared by RESS co-precipitation was
exposed to ruthenium tetraoxide (RuO4) vapor (from 1 drop of 0.5 wt. % aqueous
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RuO4 solution) at room temperature for 20 min and then analyzed using cryogenic
TEM. The TEM micrographs of sample III RDX/PS nanoparticles with and without
RuO4 vapor treatment are shown in Figure 2.18.

a

c

200 nm

50 nm

b

d

200 nm

50 nm

Figure 2.18 TEM micrographs of RESS produced nanoparticles. Two micrographs
on the left are the RESS co-precipitated sample III RDX/PS nano-composite (205 bar,
53 °C): powder stained by RuO4 (a) and without staining (b). Two micrographs on the
right are RESS recrystallized sample I nano-RDX (200 bar, 52 °C): powder stained by
RuO4 (c) and without staining (d).

RuO4 staining was very effective for enhancement of the contrast between
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RDX and PS. The thin layer visible around the particles corresponds to the stained
polystyrene. The TEM image (Figure 2.18a) clearly shows that the polystyrene layer
completely covers the RDX core. The thickness of the dark PS coating is estimated as
ca. 8 nm. Estimated weight fraction of the polymer from the film thickness is 30 ± 7%
(which corresponds to the RDX weight fraction of 70 ± 7%), in excellent agreement
with the GC-MS and XRPD determinations. From this analysis it can be concluded
that a core/shell structure with RDX at the core is formed. In order to rule out the
possibility of the dark layers shown in Figure 2.18a being solely due to the RuO4
deposition, binder free RDX nanoparticles (Sample I) were treated similarly by RuO4
vapor. After such treatment, no such layer is visible in the TEM images when no
polymer is present (Figure 2.18c). The particles appearance is identical to that of
RDX particles untreated by RuO4 (Figure 2.18d). This further confirms that the dark
shells in the particle images shown in Figure 2.18a are composed of polystyrene
Comparison of the TEM micrographs (Figure 2.18a) of stained RDX/PS
nanocomposite particles and nano-particles of RDX indicates that PS evenly
encapsulates the core. The average size of the RDX/PS nanocomposite particle is ca.
150 nm. Samples of TEM images of stained RDX/PS produced at different pressures
are shown in Figure 2.19. The coating layer is resolved for samples made at different
pressures. The core-shell structure was stable and not influenced by the process
conditions.
2.4.7
Electron Energy
Microscopy (TEM-EELS)

Loss

Spectroscopy
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in

Transmission

Electron

TEM-EELS is a powerful tool to analyze microstructures; it can reveal morphologies
of different chemical elements contained in a microscopic object. In the
RDX/VDF-HFP22 nano-composites, only RDX contains element oxygen, while only
the polymer (VDF-HFP22) contains element fluorine.
205 bar

100 nm

a

100 nm

c

100 nm

b

Figure 2.19 TEM micrographs of RESS co-precipitated RDX/PS nano-composite
stained by RuO4. a) sample III prepared at 205 bar, 53 °C. b) sample IV prepared at
150 bar, 50 °C. c) sample V prepared at 130 bar, 51 °C.

The Zero-loss micrograph of the agglomerate of the VDF-HFP22 coated RDX
nanoparticles is shown in Figure 2.20a, the micrograph of oxygen mapping (RDX
only) of the same sample is shown in Figure 2.20b. The size of the coated
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RDX/VDF-HFP22 particles is estimated as ca. 50 nm from the zero loss micrograph.
The oxygen mapping (Figure 2.20b) exhibits the same shape and morphology of the
RDX nanoparticle agglomerate as the TEM Zero-Loss micrograph (Figure 2.20a).
However, the particles are smaller.

a

b

200 nm

200 nm

Figure 2.20 TEM-EELS micrographs of RESS co-precipitated RDX/VDF-HFP22
nano-composite. (a) zero loss; (b) oxygen mapping.

By comparing the Zero-loss and oxygen mapping micrographs, it is apparent
that there is a thin layer of VDF-HFP22 covered outside of the RDX nanoparticles. In
Figure 2.20a, the part inside the small square labelled “spatial drift” was used as
reference for the software to automatically adjust for the drift during the collection of
the spectrum; the part inside the “spectrum image” is the area chosen to acquire a
higher spatial resolution spectrum. This area is sampled as an array of 160 × 40 points,
and each point yields one EELS spectra. The whole sample spectrum and the
elemental composition map were extracted based on the spectrum image. By roughly
estimating the area of the nano-composite and RDX, there is 82% area of RDX inside
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the composite area. Estimating the particle diameter as 100 nm, this leads to the
coating layer thickness of 5 nm, in fair agreement with the thickness obtained by
staining procedure (9 nm).
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CHAPTER 3
CO-PRECIPITATION OF IBUPROFEN
AND POLYMERS COMPOSITE BY RESS

3.1 Materials
Ibuprofen (98+%, GC grade) was purchased from Sigma-Aldrich. Poly (L-lactic acid)
(MW 50,000 g/mol) was purchased from Polyscience Inc. Poly (lactic-co-glycolic
acid) (LA:GA 60:40, MW 4,000 g/mol ) was purchased from Polyscitech Inc.
Polyethylene glycol (MW 20,000 g/mol) was purchased from Fluka. Common organic
solvents were used as purchased. Ethanol (99.9%, HPLC grade) was purchased from
Sigma-Aldrich. Dichloromethane (99.9%, HPLC grade) was purchased from
Sigma-Aldrich. Carbon dioxide (99.8+%, bone dry grade) pressurized with helium
was purchased from Airgas.

3.2 Results and Discussion

3.2.1 Optical Microscopy
RESS recrystallized ibuprofen particles and co-precipitated ibuprofen/polymer
particles were characterized using optical microscope equipped with an ICCD camera.
Sample images of particles produced at 140 bar and 56 °C are shown in Figure 3.1.
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3 μm

a. RESS ibuprofen

3 μm

b. RESS PLLA

3 μm

d. RESS ibuprofen

c. RESS ibuprofen/PLLA

3 μm

e. RESS PLGA

3 μm

g. RESS ibuprofen

3 μm

3 μm

f. RESS ibuprofen/PLGA

3 μm

h. RESS PEG

3 μm

i. RESS ibuprofen/PEG

Figure 3.1 Optical microscopy images of pure RESS ibuprofen (a, d, g) particles
pure RESS polymer particles (b, e, h) and RESS co-precipitated ibuprofen/PLLA,
ibuprofen/PLGA, ibuprofen/PEG composite particles (c, f, i).
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In this run, ibuprofen and the polymer were loaded to the respective extraction
vessels with the mass ratio of 1:4. The co-precipitated particles are larger than the
particles produced in expansion of supercritical solutions containing single
components. Amorphous polymer PLGA has lower molecular weight compared to
PLLA and PEG, which are semi crystallized polymers, respectively. As it was found,
at the conditions used in this work the concentration of the SC solutions is governed
by the transport phenomena rather than by the solubility of the solutes. Dissolution of
polymers is accompanied by the plasticization and swelling caused by the penetration
of CO2 into the polymer (35). PLGA has lower molecular weight and is amorphous,
both factors increasing the rate of penetration of CO2 molecules (49). This leads to
higher concentrations of PLGA in the SC solutions, and, subsequently, to larger
particles.

3.2.2 Particle Size Distribution
To evaluate the particle size distribution, 30 images of each sample were randomly
captured, containing ca. 300 particles. The distribution functions were obtained by
manually measuring each particle area using Image-Pro Plus 6.0 software and
calculating their equivalent diameter (according to the equation: A = (d/2)2, where A
is the spot area, and d is the equivalent diameter). The size distributions of the
ibuprofen particles obtained by RESS re-crystallization at different conditions are
shown in Figure 3.2. The average particle size depends on the pre-expansion
temperature and pressure. The load of ibuprofen in the extraction vessel also has
impact on the particle size.
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a

b

c

d

e

f

Figure 3.2 The particle size distribution of RESS recrystallized ibuprofen produced
at different conditions. a: 80 bar 56 °C, b: 139 bar 42 °C, c: 154 bar 53 °C, d: 167 bar
51 °C, e: 224 bar 43 °C, and f: 237 bar 44 °C.

3.2.3 Kinetics of Dissolution of Produced Powders
Dissolution kinetics of the produced powders was measured at ambient temperature
(25.0 ± 0.5 °C) as well as human body temperature (37.0 ± 0.5 °C). Weighed samples
sieved through a 150 μm mesh were introduced into 500 mL of distilled water. The
flask was continuously stirred at 50 rpm using a paddle stirrer. Aliquots (3 mL) were
sequentially withdrawn at specific time intervals. After withdrawal of a sample, equal
amount of fresh distilled water was added to the solution. The maximum dilution of
the solution caused by this sampling procedure did not exceed 12 %. The withdrawn
samples were filtered through a 0.22 μm membrane filter (Costar, USA). The amount
of ibuprofen in the withdrawn samples was determined by measuring the absorbance
at 222 nm wavelength using a UV-VIS spectrophotometer (SHIMADZU Corporation).
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Calibration experiments for UV-Vis absorbance at 222 nm were performed on
different concentrations of standard ibuprofen solution. A linear regression line was
drawn. The extinction coefficient measured using standard solutions of ibuprofen in
water is (10(222 nm) = (9.04 ±0.45)x103 L mol-1 cm-1).
Figure 3.3 shows the temporal profiles of the dissolution of the original
material as well as the produced powders at 20 °C. The dissolution rate coefficient kw
is used as a basis for comparison of the dissolution rates. It is defined as the reciprocal
time at which at which 63.2% (1-e-1) of the original amount of the drug is dissolved
(50). The dissolution rate coefficient of the RESS micronized ibuprofen is 0.002 min-1,
which is two times faster than that of the original material. The micronized ibuprofen
agglomerates upon deposition, which leads to a relatively slow dissolution. The
ibuprofen composites dissolve much faster than both the original material and the
RESS recrystallized pure ibuprofen. This is due to the polymer shell between the drug
particles which serves as a protecting layer which efficiently prevents the drug
particles from agglomeration. The dissolution rate coefficients of the RESS
co-precipitated ibuprofen/PLLA, ibuprofen/PLGA, and ibuprofen/PEG are 0.009
min-1, 0.018 min-1, and 0.02 min-1, respectively. These dissolution rates are
respectively nine, eighteen, and twenty times faster than the dissolution rate of the
unprocessed ibuprofen. Polymer PLLA is a highly crystalline and poorly soluble in
water biopolymer. Ibuprofen processed with PLLA presumably dissolves by diffusion
through a thin PLLA layer.
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25 °C

25 °C

Figure 3.3 Temporal dissolution profiles at 25 °C. Squares - pure ibuprofen, circles
- RESS recrystallized ibuprofen, triangles-up - RESS co-precipitated ibuprofen with
PLLA (ibuprofen/PLLA), triangles-down - RESS co-precipitated ibuprofen with
PLGA (ibuprofen/PLGA), and diamonds - RESS co-precipitated ibuprofen with PEG
(ibuprofen/PEG) (each point is average of three experiments). The horizontal line
corresponds to 63.2% of ibuprofen released.
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Polymer PEG is a highly water soluble polymer. PLGA dissolved in water
undergoes fast degradation caused by hydrolysis of its ester linkages (51). Dissolution
of PEG in water is fast (52). Due to the fast degradation or dissolution of the
polymeric binders in the ibuprofen/PLGA and ibuprofen/PEG composts, these
powders dissolve much faster.
Similar measurements were also performed at the human body temperature
37 °C. In these experiments, distilled water is still used as the dissolution medium.
The results are shown in Figure 3.4. At this temperature the dissolution process is
significantly faster than the dissolution process examined at 25 °C. This is due to the
increase of the water solubility of ibuprofen ca. two times compared to the solubility
at 20 °C (53). The dissolution rate coefficient of unprocessed ibuprofen at 37°C is
0.015 min-1, which is ca. fifteen times larger than at 25 °C. The dissolution rate
coefficient

of

RESS

recrystallized

ibuprofen

and

RESS

co-precipitated

ibuprofen/PLLA is two times larger than that of unprocessed ibuprofen, and for the
RESS co-precipitated ibuprofen/PLGA and ibuprofen/PEG about, three times larger.
Ibuprofen co-precipitated with PEG is completely dissolved in 45 min while only 71 %
of the unprocessed ibuprofen is dissolved in 120 min. The dissolution rate coefficient
is summarized in table 3.1.
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Table 3.1 Dissolution Rate Coefficient (kw) for Unprocessed Ibuprofen, RESS
Recrystallized Pure Ibuprofen and RESS Co-precipitated Ibuprofen/PLLA,
Ibuprofen/PLGA, and Ibuprofen/PEG

Materials

Ibuprofen

Conditions

Dissolution T

Dissolution kw

/ °C

/ min -1

(grinded, 150 μm mesh)

25

0.0010

37

0.015

Ibuprofen,

RESS at 154 bar, 53 °C,

25

0.0020

RESS produced

150 μm mesh

37

0.031

Ibuprofen/PLLA,

RESS at 148 bar, 55 °C,

25

0.0090

RESS produced

150 μm mesh

37

0.025

Ibuprofen/PLGA,

RESS at 144 bar, 63 °C

25

0.018

RESS produced

150 μm mesh

37

0.045

Ibuprofen/PEG,

RESS at 140 bar, 63 °C

25

0.020

RESS produced

150 μm mesh

37

0.043

The RESS recrystallized ibuprofen released faster than the unprocessed
ibuprofen mainly due to the size reduction of the particles. As shown in Figure 3.4, in
the first 60 min, it is released faster than the RESS co-precipitated ibuprofen/PLLA.
PLLA coated ibuprofen is presumably released by diffusion through the PLLA
polymer layer, which hinder dissolution, compared to the dissolution of the pure
micronized ibuprofen particles. However, it might be expected, that pure micronized
ibuprofen powder contains a fraction of larger agglomerated particles, which would
slow down the dissolution at the later stages of the process. PLGA undergoes fast
disintegration upon dissolution; PEG is highly soluble in water.
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37 °C
*

Figure 3.4 Temporal dissolution profiles at 37 °C. Squares - pure ibuprofen, circles
- RESS recrystallized ibuprofen, triangles-up - RESS co-precipitated ibuprofen with
PLGA (ibuprofen/PLGA), triangles-down - RESS co-precipitated ibuprofen with
PLLA (ibuprofen/PLLA), and diamonds - RESS co-precipitated ibuprofen with PEG
(ibuprofen/PEG) (each point is average of three experiments). The horizontal line
corresponds to 63.2% of ibuprofen released.

Composites of micronized ibuprofen with these two polymers exhibit
higher dissolution rates. PLGA is an amorphous polymer with 60:40 mole ratio of
lactide to glycolide randomly blocked monomers. PLGA hydrolysis leads to lactide
and glycolide monomers breaking long polymer chains to shorter chains. This
facilitates permeation of water towards ibuprofen as well as escape of ibuprofen into
the solution. The release of ibuprofen in the case of the ibuprofen/PLGA composite is
even faster than the ibuprofen/PEG composites during the initial 30 min of the
process, as shown in Figure 3.4. Short induction periods in the dissolution of
ibuprofen/polymer composites are apparent (Figure 3.4). The induction periods are
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presumably to the dissolution of the polymers which precede release of ibuprofen into
the solution.
To check whether UV absorption of dissolved polymers interferes with the
ibuprofen absorption at 222 nm, additional experiments on dissolution of pure
polymers in water were performed at 37.0 ± 0.5 °C. The polymers were allowed to
dissolve in water when agitated with 50 rpm for 120 min. The dissolved amounts
were evaluated by measuring the absorbance at 240 nm (54), 270 nm (51), and 510
nm (55) for PLLA, PLGA, and PEG, respectively. The UV absorbance of the three
polymers is summarized in table 3.1.

Table 3.2

Polymer UV Absorbance from Literature

Polymer

Maximum UV

Molar

Solubility

Comment/

absorption

extinction

in water at

reference

wavelength λ

coefficient ε10

20 °C

/ nm

/ L mol-1 cm-1

/mg ml-1

PLLA

240 nm

not available

insoluble

In chloroform
(54)

PLGA

270 nm

not available

insoluble

In phosphate buffer
solution (51)

PEG

510 nm

1.37x105

630 mg/mL

In Dragendorff
reagent (55)

In the case of PEG, maximum absorbance at 510 nm was reached at 5 min,
with subsequent decline due to the dilution caused by the sample withdrawal
procedure. In the case PLGA, no absorbance was detected. The PLGA samples after
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the procedure were extracted, dried and weighed. The weight loss was 10%,
indicating that this amount of the polymer was left in the solution. However, no
absorbance at 270 nm was detected. In the case of PLLA, no weight loss of the
sample was detected, confirming that PLLA is not water soluble. Finally, for all three
polymers there was no absorbance observed at 222 nm (Figure 3.5).

37 °C

Figure 3.5 Control experiments on the dissolution of pure polymers at 37°C in
comparison with the dissolution of unprocessed ibuprofen. Absorbance is measured at
222 nm. Squares - PLLA precursor, circles - PLGA precursor, triangles-up - PEG
precursor, and triangles-down - unprocessed ibuprofen.

Ibuprofen is a weak acid. Its dissolution rate could be influenced by the
increase of the acidity of the dissolution medium. Therefore, a buffer solution would
be required to maintain a constant pH. However, in this study, the dissolution medium
used was distilled water. Ibuprofen has pKa of ca. 5. In the experimental procedure,
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10 mg of ibuprofen were dissolved in 500 ml of distilled water. The final pH of the
solution is 4.4.
Rivera-Leyva (56) et al. studied the dissolution kinetics of commercial
ibuprofen suspension. The dissolution rate coefficient in a buffer medium with
pH=7.2 is 0.03 min-1, and in a buffer medium with pH=4.5 is 0.02 min-1. In the buffer
medium with pH=7.2 ibuprofen was 100% released in 60 min. In the pH=4.5 buffer
medium, 90% of ibuprofen was released in 120 min. These measurements
demonstrated that the dissolution of ibuprofen is influenced by the acidity of the
medium. Although in our experiments the measurements were performed in the
conditions of changing pH in the dissolution process, the conclusions on the relative
dissolution rate are still valid, since all experiments were performed over the same pH
range.
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CHAPTER 4
MECHANISM OF PARTICLE FORMATION IN RESS

4.1 Spray-drying Model

Spray-drying is a conventional method widely used to produce small particles. In the
spray-drying process, a liquid solution is first broken into millions of droplets which
form a spray, this process is called atomization (57). Then the spray contacts with the
drying medium, usually a heated air or inert gas, where evaporation occurs.. After that
the dried product is collected at the base of the drying chamber.

In the spray-drying

process, the particle size as well as the particle size distribution is controlled by the
droplet size distribution and the solute concentration in the solution.

4.2 Tentative Particle Formation Mechanism
In the previous work it was shown that the particle size of particles precipitated by
RESS is significantly larger than the particle size expected due to the homogeneous
nucleation and growth of the solute (58). For RDX, the predicted maximum particle
size by the homogeneous nucleation and growth model was ca. 20 nm,(REFERENCE)
with the observed size of about 200 nm (depending upon the conditions), which
translates into the 1000 times discrepancy in the particle mass. For this specific
system (RDX precipitation) it was unambiguously shown that the homogeneous
precipitation and growth is not the mechanism responsible for the particle formation
in the RESS process. Alternatively, a modified spray-drying model was proposed (58).
This model is based on the observation that the RESS of SC solutions in CO2 is

53

accompanied by condensation (with subsequent evaporation) of carbon dioxide. Then
the process is equivalent to the spray-drying process which differs mainly by the fact
that the condensed phase appears in the stage of the spray formation. Additional
feature is the impact of the dissolved solute on the droplet (or crystals) condensation
dynamics and the size distribution. The model, in the first approximation, predicts the
volume of the solute particles to be proportional to the concentration of the solution,
or, alternatively, the diameter to be proportional to the cubic root of the concentration

d ~ C1/3

(4.1)

where d is the diameter of the solute particle formed, and C is the mass concentration
of the solute in the supercritical solution.
To verify the particle formation mechanism in the case of ibuprofen precipitation,
additional experiments on ibuprofen particles formation by RESS when the
concentration of dissolved ibuprofen was systematically varied were carried out. The
amounts of the dissolved ibuprofen and the polymers were accurately measured by
weighing the extraction vessels before and after each run. It was found that the weight
losses did not correspond to the solubility of these compounds in supercritical carbon
dioxide, and that the solution was not saturated either with ibuprofen or the polymers.
In addition, the weight loss was increasing with the initial load. These observations
indicate that the dissolved amounts are controlled mainly by other factors, such as the
transport and the dissolution rates.
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The main observations of this study were rationalized based on the modified
spray-drying mechanism (58).
Upon expansion, the stream of the supercritical solution undergoes fast
cooling which leads to the formation of liquid carbon dioxide or, at lower downstream
pressures, dry ice. The entrained quantities of the solutes in the droplets are
proportional to their concentrations in the supercritical solution. Subsequently, carbon
dioxide evaporates or sublimes, leaving solid composite particles consisting of the
entrained solutes.
.

Figure 4.1 The particle size distribution of RESS recrystallized ibuprofen produced
at different conditions. a: 80 bar 56 °C, b: 139 bar 42 °C, c: 154 bar 53 °C, d: 167 bar
51 °C, e: 224 bar 43 °C, and f: 237 bar 44 °C. Filled squares are the mean diameter,
open squares are the diameters in the maxima of the distribution functions, and the
error bars are ±1standard deviation.
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To check the particle size dependence on the solution concentration predicted
by the modified spray-drying mechanism (4.1) recrystallization of ibuprofen by RESS
was conducted at different conditions. Concentration of ibuprofen in the supercritical
solutions was varied by varying the load and pressure. Figure 4.1 shows the plot of
the average particle size vs. the cubic root of the solution concentration. The measured
dependence is linear and goes through the origin which is in accord with the
suggested mechanism.
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CHAPTER 5
SOLUBILITY OF COMPOUNDS IN SUPERCRITICAL CARBON DIOXIDE

5.1 Polymer Dissolution in Liquid Solvent

The process of polymer dissolution differs significantly from the process of
dissolution of material made of small size small molecules. For non-polymeric
materials, the rate of the “external” mass transfer controls the rate of the dissolution
process. For polymers, the dissolution rate is usually controlled either by the solvent
diffusion or the disentanglement of the polymer chains (59). As a result, polymers do
not dissolve “instantaneously”.
Crank (60) summarized the structure of the glassy polymers during dissolution
above its gel temperature.
1. The infiltration layer: the solvent molecules penetrate into the polymer free
volumes.
2. The solid swollen layer: more and more solvent penetrate into the polymer, new
holes created but the polymer is still in the glassy state.
3. The gel layer: as the polymer becomes swollen by the solvent molecules, it is in
the rubber-like state.
4. The liquid layer: this layer surrounds the internal undissolved solid layers.

For dissolution below a certain temperature, the gel layer is not formed.
Instead extensive cracking inside the polymer matrix occurs which facilitates the
solvent penetration. This specific temperature is defined as the gel temperature of the
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polymer. Therefore, the variation in the free volume and the stiffness of the polymer
play an important role for controlling the polymer behavior
Higher molecular weight polymers dissolve slower because they have higher
degree of chain entanglement which will make the swelling process much longer than
that for the lower molecular weight polymers. Also they are packed more densely
with less pores and cracks or other kind of imperfections (49), which slow down the
solvent diffusion process.
From the thermodynamic view, the dissolution of a polymer in a solvent is
governed by the free energy of mixing (61):

ΔGm = ΔHm - TΔSm

(5.1)

where ΔGm is the molar Gibbs free energy of mixing, ΔHm is the enthalpy of
mixing, T is the absolute temperature, and ΔSm is the entropy of mixing. Since the
dissolution of polymers is usually accompanied with a small positive entropy change,
the enthalpy change becomes the controlling factor. The enthalpy of mixing is given
by

ΔHm = Vmix [(ΔEv1/V1)1/2 - (ΔEv2/V2)1/2]2 Φ1 Φ2

(5.2)

where Vmix is the volume of the mixture, ΔEVi is the energy of vaporization of species
i; Vi is the molar volume of species i; and Φi is the volume fraction of i in the mixture.
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The Hildebrand solubility parameter δ is defined as (59)

δ = (E/V)1/2

(5.3)

where E is defined as the increase in the internal energy per mole of the material if in
the process of elimination of all of the intermolecular forces E is also called the the
cohesive energy. V is the volume of the material per mole, E/V is the cohesive energy
density. Parameter δ has the same meaning as the term (ΔEvi/Vi)1/2 in Equation 5.2.
Therefore, the enthalpy of mixing can be rewritten as:

ΔHm = Vmix [(δ1 - δ2)]2 Φ1 Φ2

(5.4)

In order to the dissolution process to occur spontaneously, the Gibbs free energy of
mixing must be negative. Therefore the ΔHm term should be smaller than the TΔSm
term in Equation 5.1. From Equation 5.4, to make ΔHm small, δ1 - δ2 should be as
small as possible. It means that the solubility parameter difference between the solute
and solvent should be small in order to make the solute readily dissolved in the
solvent. This principle is also known as ‘like dissolves like’.
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Table 5.1 Solubility Parameter Calculations of RDX and Binders
Chemical

RDX

Atoms & groups

3 NO2

Δ Ev

V

δ

cal/mol

cm3/mol

(cal/cm3)1/2

1.519×104

137.8

10.49

1.219×104

255.7

6.910

9.630×103

94.50

10.10

3.901×104

315.9

11.11

3 CH2
3N
6 member ring
VDF-HFP22

5 CF2
4 CH2
1 CF3
1C
1F
10 main chain

PS

1 CH
1 CH2
1 C=
5 CH=
3 conjugated
double bonds
1 6-member ring

AMC

6 member ring
CH3
NH2
CO
O
CH=
C=
4 conjugated
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Fedors et al. (62) developed the group contribution method to estimate the
solubility parameters δ:

ΔEv 1/2

δ=(

v

)

∑ 𝛥𝑒𝑖

= (∑𝑖 𝛥𝑣𝑖)1/2

(5.5)

𝑖

Δei is atomic and group contributions to the energy of vaporization per mole, and Δvi
is the atomic and group contributions to the molar volume at a specific temperature.
At room temperature, δCO2 equals 5.96 (61) and δRDX equals 10.49 (7). The calculated
solubility parameter at room temperature of the chemicals used in this work, which
was listed in Table 3. We find that VDF-HFP22 is the most favored in CO2.

5.2 Polymer Dissolution in Carbon Dioxide
The polymer dissolution in supercritical carbon dioxide will include several steps (63)
as shown in Figure 5.1:
1. CO2 molecule absorb on the surface of the polymer.CO2 molecule diffuses into
the polymer matrix.
2. CO2 concentration inside the polymer reaches a critical concentration where the
polymer chains have enough space to disentangle from each other and start to
dissolve into the solvent. The dissolution rate is low, the process is still CO2
adsorption/absorption controlled.
3. The polymer dissolution rate increases to be higher than the CO2
adsorption/absorption rate. The polymer dissolution occurs much faster, the
process become polymer dissolution controlled.
For most polymers, its solubility in supercritical carbon dioxide increases
dramatically and non-linearly as the pressure increased. This is because at higher
pressure the density of carbon dioxide is much higher. The solubility of polymers
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in CO2 drops sharply as a function of molecular weight. However, complete
dissolution of the polymer film is normally not achieved. The non-soluble part
may due to having a high molecular weight or a high degree of entanglement.

Figure 5.1 Schematic showing the difference phenomena involved during the
dissolution process of polymer films (63).

5.2.1 Factors that Influence Polymer Solubility in Supercritical Carbon Dioxide
From lattice solution theory, three factors may influence polymer solubility in
supercritical carbon dioxide, which are solute-solute interactions, solute-solvent
interactions, and solvent-solvent interactions. CO2-CO2 interaction is negligible as
compared to the other two factors. A difference in the solubility parameter between a
polymer and carbon dioxide would be a representative factor for solute-solvent
interaction. O’Neil (64) stated that the surface tension of the polymer is a reliable
measurement of cohesive energy density for the polymer-polymer interactions. From
the cloud point measurement, it is concluded that polymers solubility in carbon
dioxide at temperatures below 80 °C is inversely proportional to the surface tension of
the polymer, which demonstrated that the solubility is governed primarily by the
polymer-polymer interactions. The polymer-CO2 interactions play a secondary role.
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The free volume inside the polymer is also an important factor that influences the
polymer solubility in supercritical carbon dioxide (65). It is known, that glassy
polymers have lower solubility and dissolution rate compared to completely
amorphous polymers (65). The polymers which were used to produce composites with
ibuprofen have different crystallinity: PLLA has crystallinity 37% (66), PEG and
PLGA are amorphous. This explains the trend in the particle size of these polymers
when crystallized by RESS separately.

5.2.2 Polymer Solubility in Supercritical Carbon Dioxide
Rindfleish (65) experimentally tested cloud-point data of polymers and copolymers in
supercritical CO2 up to 27 ℃ and 3000 bar. The solubility of PS (MW 1850 g/mol)
is low and below the sensitivity (0.1 wt %) of the cloud-point technique. At 70 ℃,
VDF-HFP22 has cloud-point pressure of 700 bar. At higher temperatures, the
cloud-point pressures are even higher. VDF-HFP22 is relatively more soluble than PS
in CO2 because of its fluorine content and the copolymer block in the chain. Also, PS
has a Tg of 103 ℃, which indicates that PS has a stiffer chain backbone and have less
rotational flexibility of the chain segments. This results in a higher entropy penalty for
CO2 to dissolve PS.
Fluorinating a hydrocarbon polymer improves its solubility in CO2, because
the carbon atom in CO2 and the fluorine atom in the polymer repeating unit form a
weak complex C-F at low temperatures (67). CO2 can act as an electron acceptor to
form Lewis acid-base complexes with polymers that possess electron donating groups,
such as fluorine atoms. The hexafluoro propylene (HFP) comonomer disrupts the
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stereo regularity of -VDF and thus renders it amorphous. Vinylidene fluoride (VDF)
co-monomer introduces polarity into the backbone of VDF-HFP22. Dipole of –VDF
interacts favorably with the quadrupole of CO2, which overshadows CO2-CO2
quadrupolar interactions. VDF-HFP22 can dissolve in CO2 at modest pressures and
temperatures as low as 0 ℃ due to the dominance of the polar interactions at low
temperatures. O’Neil (64) et al. experimentally measured the solubility of PS at 207
bar, and 35 ℃, The low molecular weight PS (MW 500 g/mol) is slightly soluble («
0.1 wt %). However, the PS with MW of 1850 g/mol is “insoluble” in supercritical
CO2. Then the PS used in the current experiments with the MW of 250000 g/mol
should be considered as insoluble in CO2 under the same conditions. As mentioned in
our previous work (1), RDX is slightly soluble (0.2 wt %) in CO2 at 35 ℃, 200 bar.
The solubility can be also discussed based on the solubility parameter δ /(cal /
cm3)1/2 (62). At 25 ℃, δ (CO2) is 5.96, δ (RDX) is 10.49 (7) and δ (PS) (density of
1.06 g / cm3) is 9.10 (68). Based on the group contribution method as shown in Table
5.1., δ (VDF-HFP22) is calculated as 6.91. VDF-HFP22 has the closest δ value to CO2,
as compared to RDX and PS, which means it is more favorable in CO2 at 25 ℃. This
is in accord with the cloud point measurements. The solubility in CO2 can be arranged
from high to low as VDF-HFP22 > RDX > PS.
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CHAPTER 6
CONCLUSIONS

The technique of production of composite nano- and micron sized materials using
Rapid Expansion of Binary Supercritical Solutions was explored and characterized.
The technique was applied to two systems: production of nanocrystalline polymer
coated energetic materials and micron sized drug – biocompatible polymer
composites. The specific results are:
Nanoparticles of RDX coated with PS or VDF-HFP22 polymer films were
produced by co-precipitation in rapid expansion of supercritical solutions (RESS).
The morphology of produced nanoparticles was characterized by SEM and TEM. The
size of produced RDX nanoparticles is ca. 100 nm. The X-ray powder diffraction
indicates that the particles are polycrystalline with crystallite size of 42 nm (similar to
the crystallite size for pure nano-RDX, 44 nm). However, RDX diffraction indicates
much larger internal strain of the particles. The RDX mass fraction in the produced
powders was in the range 70-82%, as analyzed using GC-MS and XRPD. TEM
analysis of the RDX/PS nanocomposites assisted by selective staining of the polymer
phase showed ca. 10 nm shell layer of polystyrene on the RDX core. The observations
indicate core-shell structure of the products rather than separate precipitation of the
components. RDX was also co-precipitated with AMC, a fluorescent dye compound
for evaluation using optical fluorescence microscopy with evanescent excitation.
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Comparison of the usual optical images and the images acquired via fluorescence
indicates that all produced particles contain the fluorescent dye. No RDX
nanoparticles free of dye have been observed.
Micro-particles composite of ibuprofen with bio-compatible polymers were
also produced by co-precipitation in rapid expansion of supercritical solutions (RESS).
The morphology of produced nanoparticles was characterized by optical microscopy.
The size of produced particles is 3-10 microns. Although RESS of pure materials
produces nano- or micron-sized particles, there are no means to prevent their
agglomeration. Reduction of the size of particles of energetic materials leads to
reduction of their sensitivity to external stimuli (38). Micronization of drug particles
enhances their bioavailability and the dissolution rate. Co-precipitation of a drug and
bioavailable polymers composites can either accelerate or slow down the drug release
depending on the chosen polymer. Kilogram to 100 kg level quantities can be
produced. The particles size is controlled by varying the experimental conditions (e.g.,
pressure, load). RESS co-precipitation is a simple one step process. It could be binary
or multi-component production. It is environmental friendly, organic solvent free,
clean and economic.
The product was evaluated with SEM, TEM, XRD, and GC-MS. Core-shell
structure of RESS co-precipitated RDX/PS was demonstrated. It will reduce
agglomeration of the particles and enhance functionality. The dissolution profile was
examined on RESS co-precipitated ibuprofen and polymers. Remarkable dissolution
enhancement was achieved by the co-precipitated composite as compared to
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unprocessed ibuprofen. The approach can be extended to other energetic or drug
materials with a wide field of applications.
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